ViaDerma, Inc. (VDRM)
OTCMKTS
· Delayed Price · Currency is USD
0.0010
-0.0024 (-70.59%)
May 19, 2025, 4:00 PM EDT
ViaDerma Revenue
In the year 2017, ViaDerma had annual revenue of $44.69K, down -82.26%. ViaDerma had revenue of $17.89K in the quarter ending December 31, 2017, a decrease of -99.69%.
Revenue
44.69K
Revenue Growth
-99.75%
P/S Ratio
16.56
Revenue / Employee
595.88
Employees
75
Market Cap
740.23K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| BioStem Technologies | 332.45M |
ViaDerma News
- 9 months ago - ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria - GlobeNewsWire
- 10 months ago - ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires - GlobeNewsWire
- 1 year ago - ViaDerma Provides Highlights of Quarterly Financial Report - GlobeNewsWire
- 1 year ago - ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More - GlobeNewsWire
- 2 years ago - ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product - GlobeNewsWire
- 2 years ago - ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product - GlobeNewsWire
- 2 years ago - ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development - GlobeNewsWire
- 2 years ago - ViaDerma Successfully Completes Quality Control Testing of its New Vitastem Products - GlobeNewsWire